Endothelial function and common carotid artery wall thickening in patients with essential hypertension

Hypertension

Volumn 32, Issue 1, 1998, Pages 25-32

  Ghiadoni, Lorenzo ^b   Taddei, Stefano ^a   Virdis, Agostino ^b   Sudano, Isabella ^b   Di Legge, Virgilio ^b   Meola, Mario ^b   Di Venanzio, Lorenzo ^b   Salvetti, Antonio ^b  

^a UNIVERSITY OF PISA   (Italy)

^b NONE

Author keywords

Acetylcholine; Carotid arteries; Endothelium; Hypertension, essential; Sodium nitroprusside

Indexed keywords

ACETYLCHOLINE; CHOLESTEROL; GLUCOSE; NITROPRUSSIDE SODIUM;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; B SCAN; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; FOREARM BLOOD FLOW; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE MASS; HUMAN; MALE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASODILATATION;

EID: 0031903105     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.1.25     Document Type: Article

References (50)

1. Wilson PWF, Kannel WB. Hypertension, other risk factors and the risk of cardiovascular disease. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Treatment. New York, NY: Raven Press Publishers; 1995:99-114.
2. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500.
3. Chobanian A. Pathophysiology of atherosclerosis. Am J Cardiol. 1992; 70:3G-7G.
4. Yasue H, Matsuyama K, Matsuyama K, Okamura K, Morikami Y, Ogawa H. Response of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment: possible role of early coronary atherosclerosis. Circulation. 1990;81:482-490.
5. Davis SF, Yeung AC, Meredith IT, Charbonneau F, Ganz P, Selwyn P, Anderson TJ. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year post transplant. Circulation. 1996;93:457-462.
6. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for the release of endothelium-derived relaxing factor in the human forearm circulation in vivo: blunted response in essential hypertension. Circulation. 1990;81:1762-1767.
7. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
8. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993;21:929-933.
9. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Basile Fasolo C, Sudano I, Salvetti A. Aging and endothelial function in normotensive subjects and essential hypertensive patients. Circulation. 1995;91: 1981-1987.
10. Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I, Bernini G, Pinto S, Salvetti A. Menopause is associated with endothelial dysfunction in women. Hypertension. 1996;28:576-582.
11. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228-234.
12. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. The role of nitric-oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation. 1993;88:2541-2547.
13. Williams SB, Cusco JA, Roddy M-A, Johnstone MT, Creager MA. Impaired nitric oxide mediated vasodilation in patients with non insulin-dependent diabetes mellilus. J Am Coll Cardiol 1996;27:567-574.
14. Ting HH, Timini FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1996;97:22-28.
15. Heitzer T, Ylä-Herttuala S, Luoma J, Kurz S, Munzel T, Just H, Olschewski M, Drexler H. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: role of oxidized LDL. Circulation. 1996;93:1346-1353.
16. Poli A, Tremoli E, Colombo A. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients: a new model for the quantification and follow up of preclinical atherosclerosis in living human subjects. Atherosclerosis. 1988;70:253-261.
17. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991;11:1245-1249.
18. Grouse JR III, Craven TE, Hagaman AP, Bond G. Association of coronary disease with segment specific intimal-medial thickening of the extracranial carotid artery. Circulation. 1995;92:1141-1147.
19. Borhani NO, Mercuri M, Borhani PA, Buckalew VM, Canossa-Terris M, Carr AA, Kappadoga T, Rocco MV, Schnaper HW, Sowers JR, Bond G. Final outcome results of the multicenter isradipine diuretic atherosclerosis study (MIDAS). JAMA. 1996;276:785-791.
20. Devereux RB, Alonso DR, Lertas EM, Gottlib GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular mass: comparison to necropsy findings. Am J Cardiol 1986;57:450-458.
21. Whitney RJ. The measurement of volume changes in human limbs. J Physiol (Lond). 1953;121:1-27.
22. Pedrinelli R, Taddei S, Graziadei L, Salvetti A. Vascular responses to ouabain and norepinephrine in low and normal renin hypertension. Hypertension. 1986;8:786-792.
23. Schultz KD, Schultz K, Schultz G. Sodium nitroprusside and other smooth muscle relaxants increase cyclic GMP levels in rat ductus deferens. Nature. 1977;265:750-751.
24. Pedrinelli R, Taddei S, Spessot M, Salvetti A. Maximal postischemic forearm vasodilation in human hypertension: a reassessment of the method. J Hypertens. 1987;5(suppl 5):S431-S433.
25. Agabiti-Rosei E, Rizzoni D, Castellano M, Porteri E, Zulli R, Muiesan ML, Bettoni G, Salvetti M, Muiesan P, Giulini SM. Media:lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens. 1995;13:341-347.
26. Schiffrin LE, Deng LY. Structure and function of resistance arteries of hypertensive patients treated with a β-blocker or a calcium channel antagonist. J Hypertens. 1996;14:1247-1255.
27. Folkow B. The structural factor in hypertension with special emphasis on the altered geometric design of the systemic arteries. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Treatment. New York, NY: Raven Press Publishers: 1995:481-502.
28. Devereux RB, Pickering TG, Harshfield GA, Kleinert HD, Denby L, Clark L, Pregibon B, Jason M, Kleiner B, Borer JS, Laragh JH. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation. 1983;68:1550-1558.
29. Rizzoni D, Muiesan ML, Porten E, Castellano M, Zulli R, Bettoni G, Salvetti M, Monteduro C, Agabiti-Rosei E. Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J Hypertens. 1997;15:197-204.
30. Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Salvetti A. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation. 1996;94:1298-1303.
31. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiff. 1993;21:1145-1151.
32. Creager MA, Roddy MA. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension. 1994;24:499-505.
33. Kiowski W, Linder L, Nuesch R, Martina B. Effect of cilazapril on vascular structure and function in essential hypertension. Hypertension. 1996;27(pt 1):371-376.
34. Roman MJ, Saba PS, Pini R, Spitzer M, Pickering TG, Rosen S, Alderman MH, Devereux RB. Parallel cardiac and vascular adaptation in hypertension. Circulation. 1992;86:1909-1918.
35. Cuspidi C, Lonati L, Sampieri L, Pellizzoli S, Pontiggia G, Leonetti G, Zanchetti A. Left ventricular concentric remodeling and carotid structural changes in essential hypertension. J Hypertens. 1996;14:1441-1446.
36. Gariepy J, Simon A, Massonneau M, Linhart A, Segond P, Levenson J, Groupe PCVMETRA. Echographic assessment of carotid and femoral arterial structure in man with essential hypertension. Am J Hypertens. 1996;9:126-136.
37. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87: 1468-1474.
38. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension. 1997;29(pt 2):274-279.
39. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987; 2:1057-1068.
40. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83: 1774-1777.
41. Dubey RK, Ganten D, Lüscher TF. Enhanced migration of smooth muscle cells from Ren-2 transgenic rats in response to angiotensin II: inhibition by nitric oxide. Hypertension. 1993;22:412. Abstract.
42. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leucocyte adhesion. Proc Natl Acad Sci U S A. 1991;88:4651-4655.
43. De Caterina R, Libby P, Peng HB, Thannichal VJ, Rajavashisth TB, Gimbrone MA, Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation. J Clin Invest. 1995;96:60-68.
44. 2 in endothelium in maintaining resting tone and producing contractile response to acetylcholine and arachidonic acid in canine cerebral arteries. Blood Vessels. 1987;24:117-119.
45. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986;320:454-456.
46. Alexander RW. Hypertension and the pathogenesis of atherosclerosis. Hypertension. 1995;25:155-161.
47. Clozel M, Kuhn H, Hefti F, Baumgartner HR. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension: effect of angiotensin converting enzyme inhibition. Hypertension. 1991;18: 132-141.
48. Taddei S, Virdis A, Mattei P, Ghiadoni L, Basile Fasolo C, Sudano I, Salvetti A. Hypertension causes premature aging of endothelial function in humans. Hypertension. 1997;29:736-743.
49. Folsom AR, Wu KK, Shahar E, Davis CE, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Association of homeostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. Arterioscler Thromb. 1993;13: 1829-1836.
50. Folsom AR, Eckfeldt JH, Weitman S, Ma J, Chambless LE, Barnes RW, Cram KB, Hutchinson RG, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke. 1994;25:66-73.